1995
DOI: 10.1152/ajpregu.1995.269.5.r1189
|View full text |Cite
|
Sign up to set email alerts
|

ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure

Abstract: In cardiac failure, efferent renal sympathetic nerve activity (ERSNA) and the activity of the renin-angiotensin system are increased, and arterial baroreflex regulation of ERSNA is attenuated. We examined the effect of intravenous and intracerebroventricular angiotensin II AT receptor blockade with losartan on the arterial baroreflex regulation of ERSNA in conscious control (C) and congestive heart failure (CHF) rats. Intravenous losartan (10 mg/kg, 21.7 mumol/kg) decreased arterial pressure more in CHF than i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
123
1
2

Year Published

1999
1999
2018
2018

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 112 publications
(135 citation statements)
references
References 0 publications
9
123
1
2
Order By: Relevance
“…In rats with CHF, intracerebroventricular losartan had no effect on arterial pressure but decreased the basal level of RSNA and improved both the arterial and cardiopulmonary baroreflex control of RSNA, and chronic intraperitoneal losartan administration produced an improvement in the ability to excrete both acute and chronic sodium loads. 32,33 This led to an examination of the effect of physiological changes in the activity of the renin-angiotensin system on arterial baroreflex control of RSNA in normal rats by using the intervention of alterations in dietary sodium intake. Intracerebroventricular losartan, although not affecting arterial pressure, decreased the basal level of RSNA and shifted the arterial baroreflex control of RSNA to a lower arterial pressure in proportion to the degree of activation of the renin-angiotensin system.…”
Section: The Presentmentioning
confidence: 99%
“…In rats with CHF, intracerebroventricular losartan had no effect on arterial pressure but decreased the basal level of RSNA and improved both the arterial and cardiopulmonary baroreflex control of RSNA, and chronic intraperitoneal losartan administration produced an improvement in the ability to excrete both acute and chronic sodium loads. 32,33 This led to an examination of the effect of physiological changes in the activity of the renin-angiotensin system on arterial baroreflex control of RSNA in normal rats by using the intervention of alterations in dietary sodium intake. Intracerebroventricular losartan, although not affecting arterial pressure, decreased the basal level of RSNA and shifted the arterial baroreflex control of RSNA to a lower arterial pressure in proportion to the degree of activation of the renin-angiotensin system.…”
Section: The Presentmentioning
confidence: 99%
“…All rats showed increased heart/body weight ratio compared with normal values of Ϸ0.40% in sham or control rats in our laboratory. 14,15,17 All rats had increased LVEDP compared with normal values of Ϸ3.0 mm Hg in sham or control rats in our laboratory. 14,15,17 At autopsy, all rats had bilateral hydrothorax and ascites, which reflects their avid Figure 1.…”
Section: Discussionmentioning
confidence: 69%
“…A previously described technique [13][14][15][16][17] involving ligation of the left coronary artery was used to produce chronic CHF. Rats were anesthetized with methohexital sodium (50 mg/kg IP); an oral endotracheal tube was inserted, and mechanical ventilation with room air was instituted.…”
Section: Congestive Heart Failurementioning
confidence: 99%
“…Muitas substâncias humorais estão elevadas na IC, das quais podemos citar a angiotensina II, conhecida há algum tempo por modular a descarga simpática, pois quando se efetua bloqueio dos receptores AT1 para a angiotensina II, percebe-se uma redução do tônus simpático no estado de IC [49][50][51][52][53][54] .…”
Section: Autorunclassified